» Articles » PMID: 15194461

Inhibition of IkappaB Phosphorylation in Cardiomyocytes Attenuates Myocardial Ischemia/reperfusion Injury

Overview
Journal Cardiovasc Res
Date 2004 Jun 15
PMID 15194461
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Reperfusion injury is related closely to inflammatory reactions such as activation of inflammatory cells and expression of cytotoxic cytokines. We investigated the efficacy of IkappaB phosphorylation blockade in a rat myocardial ischemia/reperfusion injury model.

Methods And Results: IMD-0354 inhibited phosphorylation of IkappaBalpha and nuclear translocation of nuclear factor-kappa B (NF-kappaB) induced by tumor necrosis factor-alpha (TNF-alpha) in cultured cardiomyocytes. TNF-alpha-induced production of interleukin-1beta and monocyte chemoattractant protein-1 from cultured cardiomyocytes was reduced significantly by IMD-0354. Transient left coronary artery occlusion (30 min) and reperfusion (24 h) were carried out in Sprague-Dawley rats. IMD-0354 (1, 5, 10 mg/kg) was injected intraperitoneally 5 min before the start of reperfusion. Treatment with IMD-0354 resulted in a significant dose-dependent reduction of the infarction area/area at risk ratio (vehicle, 47.0+/-3.4%; 10 mg/kg of IMD-0354, 19.4+/-4.0%; P<0.01) and the preservation of fractional shortening ratio (vehicle, 25.0+/-1.5%; 10 mg/kg of IMD-0354, 42.3+/-1.7%; P<0.01). Histological analysis showed that accumulation of polymorphonuclear neutrophils in the area at risk was decreased significantly.

Conclusions: Inhibition of nuclear translocation of NF-kappaB by IkappaBalpha phosphorylation blockade could provide an effective approach to attenuation of ischemia/reperfusion injury. The cardioprotective effects of IMD-0354 include not only reduction of harmful neutrophil accumulation in myocardium but also inhibition of harmful cytokine and chemokine production by cardiomyocytes.

Citing Articles

Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.

Al Subait A, Alghamdi R, Ali R, Alsharidah A, Huwaizi S, Alkhodier R Int J Mol Sci. 2025; 26(2).

PMID: 39859448 PMC: 11766124. DOI: 10.3390/ijms26020736.


Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination.

Koller B, Jania L, Li H, Barker W, Melander R, Melander C Antimicrob Agents Chemother. 2024; 68(10):e0067124.

PMID: 39194205 PMC: 11459950. DOI: 10.1128/aac.00671-24.


Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.

Hilgendorf I, Frantz S, Frangogiannis N Circ Res. 2024; 134(12):1718-1751.

PMID: 38843294 PMC: 11164543. DOI: 10.1161/CIRCRESAHA.124.323658.


Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials.

Konaklieva M, Plotkin B Antibiotics (Basel). 2023; 12(9).

PMID: 37760715 PMC: 10525673. DOI: 10.3390/antibiotics12091418.


Cation flux through SUR1-TRPM4 and NCX1 in astrocyte endfeet induces water influx through AQP4 and brain swelling after ischemic stroke.

Stokum J, Shim B, Negoita S, Tsymbalyuk N, Tsymbalyuk O, Ivanova S Sci Signal. 2023; 16(788):eadd6364.

PMID: 37279286 PMC: 10369355. DOI: 10.1126/scisignal.add6364.